60 Degrees Pharmaceuticals, INC.
SEC CIK 1946563 · SXTP · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| DOW Geoffrey S | Director · President and CEO | filed 2023 - 2026 |
| Francois Eric | Director | filed 2026 - 2026 |
| XU Cheryl | Director | filed 2023 - 2025 |
| Allen Charles W | Director | filed 2023 - 2024 |
| Field Paul | Director | filed 2023 - 2024 |
| Toovey Stephen | Director | filed 2023 - 2024 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Landon Kristen | Chief Operating Officer | filed 2025 - 2025 |
| Miller Tyrone | Chief Financial Officer | filed 2023 - 2025 |
| Smith Bryan LEE | Chief Medical Officer | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.